Latest Deep Track Capital, LP Stock Portfolio
Deep Track Capital, LP Performance:
2025 Q3: 24.84%YTD: 15.64%2024: -1.46%
Performance for 2025 Q3 is 24.84%, and YTD is 15.64%, and 2024 is -1.46%.
About Deep Track Capital, LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Deep Track Capital, LP reported an equity portfolio of $3.6 Billions as of 30 Sep, 2025.
The top stock holdings of Deep Track Capital, LP are GH, IONS, CYTK. The fund has invested 7.2% of it's portfolio in GUARDANT HEALTH INC and 7% of portfolio in IONIS PHARMACEUTICALS INC .
The fund managers got completely rid off INSMED INC (INSM), ULTRAGENYX PHARMACEUTICAL IN (RARE) and DIANTHUS THERAPEUTICS INC stocks. They significantly reduced their stock positions in ZURA BIO LTD, AUTOLUS THERAPEUTICS PLC (AUTL) and AVALO THERAPEUTICS INC (AVTX). Deep Track Capital, LP opened new stock positions in EXACT SCIENCES CORP (EXAS), LB PHARMACEUTICALS INC and UNIQURE NV (QURE). The fund showed a lot of confidence in some stocks as they added substantially to TARSUS PHARMACEUTICALS INC (TARS), MBX BIOSCIENCES INC and VAXCYTE INC (PCVX).
The top stock holdings of Deep Track Capital, LP are GH, IONS, CYTK. The fund has invested 7.2% of it's portfolio in GUARDANT HEALTH INC and 7% of portfolio in IONIS PHARMACEUTICALS INC .
The fund managers got completely rid off INSMED INC (INSM), ULTRAGENYX PHARMACEUTICAL IN (RARE) and DIANTHUS THERAPEUTICS INC stocks. They significantly reduced their stock positions in ZURA BIO LTD, AUTOLUS THERAPEUTICS PLC (AUTL) and AVALO THERAPEUTICS INC (AVTX). Deep Track Capital, LP opened new stock positions in EXACT SCIENCES CORP (EXAS), LB PHARMACEUTICALS INC and UNIQURE NV (QURE). The fund showed a lot of confidence in some stocks as they added substantially to TARSUS PHARMACEUTICALS INC (TARS), MBX BIOSCIENCES INC and VAXCYTE INC (PCVX).
Deep Track Capital, LP Annual Return Estimates Vs S&P 500
Our best estimate is that Deep Track Capital, LP made a return of 24.84% in the last quarter. In trailing 12 months, it's portfolio return was 10.36%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| exact sciences corp | 54,710,000 |
| lb pharmaceuticals inc | 52,940,800 |
| uniqure nv | 28,198,100 |
| dyne therapeutics inc | 25,300,000 |
| genmab a/s | 14,760,500 |
| tango therapeutics inc | 12,218,300 |
| imagenebio inc | 7,159,900 |
| cormedix inc | 5,815,000 |
New stocks bought by Deep Track Capital, LP
Additions
| Ticker | % Inc. |
|---|---|
| tarsus pharmaceuticals inc | 71.43 |
| mbx biosciences inc | 43.93 |
| vaxcyte inc | 39.53 |
| oruka therapeutics inc | 38.36 |
| bridgebio pharma inc | 33.33 |
| akero therapeutics inc | 31.5 |
| cidara therapeutics inc | 20.00 |
| cytokinetics inc | 17.81 |
Additions to existing portfolio by Deep Track Capital, LP
Reductions
| Ticker | % Reduced |
|---|---|
| zura bio ltd | -85.01 |
| autolus therapeutics plc | -84.76 |
| avalo therapeutics inc | -74.5 |
| climb bio inc | -50.99 |
| engene holdings inc | -50.87 |
| protagonist therapeutics inc | -47.14 |
| mind medicine mindmed inc | -40.00 |
| gh research plc | -37.5 |
Deep Track Capital, LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| invivyd inc | -6,138,980 |
| pliant therapeutics inc | -4,579,460 |
| abivax sa | -26,623,100 |
| dianthus therapeutics inc | -41,603,500 |
| inovio pharmaceuticals inc | -4,032,090 |
| insmed inc | -176,120,000 |
| upstream bio inc | -15,841,600 |
| tectonic therapeutic inc | -27,856,500 |
Deep Track Capital, LP got rid off the above stocks
Sector Distribution
Deep Track Capital, LP has about 86.7% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 86.7 |
| Others | 13.3 |
Market Cap. Distribution
Deep Track Capital, LP has about 1.6% of it's portfolio invested in the large-cap and mega-cap stocks.
- MID-CAP
- SMALL-CAP
- UNALLOCATED
- MICRO-CAP
- LARGE-CAP
| Category | % |
|---|---|
| MID-CAP | 46.3 |
| SMALL-CAP | 34.1 |
| UNALLOCATED | 15.3 |
| MICRO-CAP | 2 |
| LARGE-CAP | 1.6 |
Stocks belong to which Index?
About 66.1% of the stocks held by Deep Track Capital, LP either belong to S&P 500 or RUSSELL 2000 index.
- RUSSELL 2000
- Others
| Index | % |
|---|---|
| RUSSELL 2000 | 66.1 |
| Others | 33.9 |
Deep Track Capital, LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Deep Track Capital, LP
Deep Track Capital, LP has 56 stocks in it's portfolio. About 52.6% of the portfolio is in top 10 stocks. AKRO proved to be the most loss making stock for the portfolio. IONS was the most profitable stock for Deep Track Capital, LP last quarter.
Last Reported on: 14 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACAD | acadia pharmaceuticals inc | 0.06 | 105,085 | 2,242,510 | new | |||
| ADGI | invivyd inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AGLE | spyre therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AKRO | akero therapeutics inc | 5.30 | 4,000,980 | 189,966,000 | added | 31.5 | ||
| ALGS | aligos therapeutics inc | 0.12 | 444,110 | 4,352,280 | unchanged | 0.00 | ||
| ANIP | ani pharmaceuticals inc | 1.15 | 450,000 | 41,220,000 | reduced | -35.71 | ||
| APLS | apellis pharmaceuticals inc | 5.05 | 8,000,380 | 181,049,000 | added | 14.29 | ||
| AUTL | autolus therapeutics plc | 0.12 | 2,568,610 | 4,186,840 | reduced | -84.76 | ||
| AVTE | jade biosciences inc | 0.55 | 2,279,890 | 19,675,500 | reduced | -9.14 | ||
| AVTX | avalo therapeutics inc | 0.05 | 144,600 | 1,837,870 | reduced | -74.5 | ||
| AXSM | axsome therapeutics inc | 3.05 | 900,000 | 109,305,000 | added | 12.31 | ||
| BBIO | bridgebio pharma inc | 1.74 | 1,200,000 | 62,328,000 | added | 33.33 | ||
| BCYC | bicycle therapeutics plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BMRN | biomarin pharmaceutical inc | 0.04 | 24,856 | 1,346,200 | new | |||
| CDTX | cidara therapeutics inc | 0.80 | 300,000 | 28,728,000 | added | 20.00 | ||
| CLDX | celldex therapeutics inc new | 1.44 | 2,000,000 | 51,740,000 | unchanged | 0.00 | ||
| CMPS | compass pathways plc | 1.26 | 7,859,650 | 45,035,800 | reduced | -11.00 | ||
| CNTA | centessa pharmaceuticals plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CNTX | context therapeutics inc | 0.20 | 7,419,360 | 7,187,870 | unchanged | 0.00 | ||
| CRMD | cormedix inc | 0.16 | 500,000 | 5,815,000 | new | |||